Revolutionizing Pain Management
So Humanity Can Thrive

Sen-Jam Pharmaceutical is focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVID-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover. Using our patented proprietary technology and the accelerated 505(b)2 pathway, we are on a mission to revolutionize the way we treat pain, and the way the business of pain relief treats humanity.

The Opioid CrisisTherepeutic Pipeline

Icon Repurposing

Repurposing

Two Small Molecules

By taking two already proven to be both effective and safe molecular agents and ingenuously combining them, Sen-Jam has discovered a simple yet powerful product that very well may change the way the world views pain relief. Our patent portfolio is rich with global relevancy and our clinical studies, both executed and planned exhibit a modern ingenuity not common to our peers.

Icon Reimagining

Reimagining

Partnerships

Our strategic partnerships run the full developmental spectrum and offer a refreshingly open model for partnerships to thrive and communities to benefit in multiple ways. From licensing to distribution and beyond, we embrace an entrepreneurial can-do spirit to transform the way healthcare connects commerce to caring.

Play Video

Sen-Jam’s Head of Clinical Development speaking to hundreds of innovators and health transformers at the StartUp Health Festival during JP Morgan’s Health Conference in San Francisco, January 2019

Icon Pill

Putting an End to

The Opioid Crisis

Opioid Use Disorder is a problematic pattern of opioid use that leads to serious impairment or distress. It includes the use of prescription opoiods, heroin, or a combination of both. The intensity of withdrawal symptoms presents a significant barrier to abstinence and opioid dose reduction. Signs of chemical dependency are present within 5 days of opioid use.

100M
people suffer from chronic pain the U.S.
10-15M
people are prescribed opioids to manage pain
3-5M
people are currently diagnosed with Opioid Use Disorder*
Icon People 25
EVERY 25
overdoses results in
ONE DEATH
Overdoses occur
EVERY 17
SECONDS
and fatalities
EVERY 7
MINUTES
1.8M
overdoses
+
over 30K
deaths
annually
$700B
Estimated cost for substance abuse by the Council of Economic Advisors in 2017
Join us as we help put an end to the deadliest drug overdose crisis in American history
Icon Two Chevrons

A tragedy that has killed more people annually than the AIDS crisis, Vietnam and automobile accidents combined.

The agony of opioid withdrawal is far more debilitating than many realize.

It’s Time to Address This Head-on

Therapeutic Pipeline

Addressing Significant Unmet Needs for Opioid Use Disorder
Discovery
Screening
Preclinical
Phase 1
Phase 2
Phase 3

Icon Rx  Prescription Strength Relief

Opioid Withdrawal
Opioid Dependence
Opioid Tolerance

Icon Otc  Over the Counter Relief

Alcohol Hangover Prevention
Viral Respiratory Infections
Arthritis
Negative Vaccination Reactions

Icon Rx  Prescription Strength Relief

Opioid Withdrawal
Preclinical
Opioid Dependence
Preclinical
Opioid Tolerance
Preclinical

Icon Otc  Over the Counter Relief

Alcohol Hangover Prevention
Phase 1
Common Cold
Preclinical
Arthritis
Preclinical
Vaccine Reactions
Preclinical